Translating Pharmacomicrobiomics: Three Actionable Challenges/Prospects in 2020

Aziz RK . (2018). Interview with Prof. Ramy K. Aziz, Cairo University. The dawn of pharmacomicrobiomics. OMICS, 22, 295–297.

Clayton TA , Baker D , Lindon JC , Everett JR , and Nicholson JK . (2009). Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Natl Acad Sci USA, 106, 14728–14733.

Duan Y , Llorente C , Lang S , et al. (2019). Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature, 575, 505–511.

Haiser HJ , Gootenberg DB , Chatman K , Sirasani G , Balskus EP , and Turnbaugh PJ . (2013). Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta. Science, 341, 295–298.

Klatt NR , Cheu R , Birse K , et al. (2017). Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women. Science, 356, 938–945.

Lagier JC , Khelaifia S , Alou MT , et al. (2016). Culture of previously uncultured members of the human gut microbiota by culturomics. Nat Microbiol, 1, 16203.

Lin XB , Farhangfar A , Valcheva R , et al. (2014). The role of intestinal microbiota in development of irinotecan toxicity and in toxicity reduction through dietary fibres in rats. PLoS One, 9, e83644.

Rizkallah MR , Saad R , and Aziz RK . (2010). The Human Microbiome Project, personalized medicine and the birth of pharmacomicrobiomics. Curr Pharmacogenomics Person Med, 8, 182–193.

Zimmermann M , Zimmermann-Kogadeeva M , Wegmann R , and Goodman AL . (2019). Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature, 570, 462–467.